Telomerase reverse transcriptase mediates EMT through NF-κB signaling in tongue squamous cell carcinoma
Locoregional lymph nodes metastasis in oral tongue squamous cell carcinoma represents one of important and common prognostic factors for poor clinical outcome. The human Telomerase Reverse Transcriptase (hTERT) is one of key players in cancer metastasis and stemness, but its exact function in tongue...
Saved in:
| Published in | Oncotarget Vol. 8; no. 49; pp. 85492 - 85503 |
|---|---|
| Main Authors | , , , , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
United States
Impact Journals LLC
17.10.2017
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 1949-2553 1949-2553 |
| DOI | 10.18632/oncotarget.20888 |
Cover
Loading…
| Abstract | Locoregional lymph nodes metastasis in oral tongue squamous cell carcinoma represents one of important and common prognostic factors for poor clinical outcome. The human Telomerase Reverse Transcriptase (hTERT) is one of key players in cancer metastasis and stemness, but its exact function in tongue squamous cell carcinoma remains unknown. Here, we aim to understand the role of hTERT by utilizing the CRISPR/Cas9 gene editing system to deplete hTERT in the SCC-15 cell line. Functional comparison of SCC-15 control and knockout cells (hTERT
) showed that loss of hTERT suppressed cell proliferation and migration/invasion. Furthermore, hTERT depletion significantly decreased tumorigenesis, including alterations in cellular morphology that areindicative for epithelial-mesenchymal transition (EMT). Mechanistically we demonstrated that the hTERT knockout attenuates NF-κB signaling via a negative feedback regulation in tumorprogression. From these results we propose a novel molecular mechanism of hTERT to promote SCC-15 invasion and metastasis via NF-κB activation. We conclude that targeting hTERT may represent a new therapeutic strategy to improve therapy and survival of tongue squamous cell carcinoma patients. |
|---|---|
| AbstractList | Locoregional lymph nodes metastasis in oral tongue squamous cell carcinoma represents one of important and common prognostic factors for poor clinical outcome. The human Telomerase Reverse Transcriptase (hTERT) is one of key players in cancer metastasis and stemness, but its exact function in tongue squamous cell carcinoma remains unknown. Here, we aim to understand the role of hTERT by utilizing the CRISPR/Cas9 gene editing system to deplete hTERT in the SCC-15 cell line. Functional comparison of SCC-15 control and knockout cells (hTERT
) showed that loss of hTERT suppressed cell proliferation and migration/invasion. Furthermore, hTERT depletion significantly decreased tumorigenesis, including alterations in cellular morphology that areindicative for epithelial-mesenchymal transition (EMT). Mechanistically we demonstrated that the hTERT knockout attenuates NF-κB signaling via a negative feedback regulation in tumorprogression. From these results we propose a novel molecular mechanism of hTERT to promote SCC-15 invasion and metastasis via NF-κB activation. We conclude that targeting hTERT may represent a new therapeutic strategy to improve therapy and survival of tongue squamous cell carcinoma patients. Locoregional lymph nodes metastasis in oral tongue squamous cell carcinoma represents one of important and common prognostic factors for poor clinical outcome. The human Telomerase Reverse Transcriptase (hTERT) is one of key players in cancer metastasis and stemness, but its exact function in tongue squamous cell carcinoma remains unknown. Here, we aim to understand the role of hTERT by utilizing the CRISPR/Cas9 gene editing system to deplete hTERT in the SCC-15 cell line. Functional comparison of SCC-15 control and knockout cells (hTERT-/-) showed that loss of hTERT suppressed cell proliferation and migration/invasion. Furthermore, hTERT depletion significantly decreased tumorigenesis, including alterations in cellular morphology that areindicative for epithelial-mesenchymal transition (EMT). Mechanistically we demonstrated that the hTERT knockout attenuates NF-κB signaling via a negative feedback regulation in tumorprogression. From these results we propose a novel molecular mechanism of hTERT to promote SCC-15 invasion and metastasis via NF-κB activation. We conclude that targeting hTERT may represent a new therapeutic strategy to improve therapy and survival of tongue squamous cell carcinoma patients.Locoregional lymph nodes metastasis in oral tongue squamous cell carcinoma represents one of important and common prognostic factors for poor clinical outcome. The human Telomerase Reverse Transcriptase (hTERT) is one of key players in cancer metastasis and stemness, but its exact function in tongue squamous cell carcinoma remains unknown. Here, we aim to understand the role of hTERT by utilizing the CRISPR/Cas9 gene editing system to deplete hTERT in the SCC-15 cell line. Functional comparison of SCC-15 control and knockout cells (hTERT-/-) showed that loss of hTERT suppressed cell proliferation and migration/invasion. Furthermore, hTERT depletion significantly decreased tumorigenesis, including alterations in cellular morphology that areindicative for epithelial-mesenchymal transition (EMT). Mechanistically we demonstrated that the hTERT knockout attenuates NF-κB signaling via a negative feedback regulation in tumorprogression. From these results we propose a novel molecular mechanism of hTERT to promote SCC-15 invasion and metastasis via NF-κB activation. We conclude that targeting hTERT may represent a new therapeutic strategy to improve therapy and survival of tongue squamous cell carcinoma patients. Locoregional lymph nodes metastasis in oral tongue squamous cell carcinoma represents one of important and common prognostic factors for poor clinical outcome. The human Telomerase Reverse Transcriptase (hTERT) is one of key players in cancer metastasis and stemness, but its exact function in tongue squamous cell carcinoma remains unknown. Here, we aim to understand the role of hTERT by utilizing the CRISPR/Cas9 gene editing system to deplete hTERT in the SCC-15 cell line. Functional comparison of SCC-15 control and knockout cells (hTERT −/− ) showed that loss of hTERT suppressed cell proliferation and migration/invasion. Furthermore, hTERT depletion significantly decreased tumorigenesis, including alterations in cellular morphology that areindicative for epithelial-mesenchymal transition (EMT). Mechanistically we demonstrated that the hTERT knockout attenuates NF-κB signaling via a negative feedback regulation in tumorprogression. From these results we propose a novel molecular mechanism of hTERT to promote SCC-15 invasion and metastasis via NF-κB activation. We conclude that targeting hTERT may represent a new therapeutic strategy to improve therapy and survival of tongue squamous cell carcinoma patients. |
| Author | Bartsch, Jörg W. Zhen, Chunlin Liu, Liu Ji, Ping Yang, Li Yang, Junfeng Zhong, Julia Li Wu, Yan Huang, Enyi Jiang, Xuemei Nisar, Muhammad Farrukh Wang, Mei Lin, Zhenghong Bian, Chunxiang Yu, Yanhong |
| Author_xml | – sequence: 1 givenname: Yan surname: Wu fullname: Wu, Yan organization: Stomatological Hospital of Chongqing Medical University, Chongqing Key Laboratory of Oral Diseases and Biomedical Sciences, Chongqing Municipal Key Laboratory of Oral Biomedical Engineering of High Education, Chongqing, 401147, China, The Base of “111 Project” for Biomechanics and Tissue Repair Engineering, Key Laboratory of Biorheological Science and Technology, Ministry of Education, Bioengineering college, Life Science College, Chongqing University, Chongqing 400044, China – sequence: 2 givenname: Chunxiang surname: Bian fullname: Bian, Chunxiang organization: Stomatological Hospital of Chongqing Medical University, Chongqing Key Laboratory of Oral Diseases and Biomedical Sciences, Chongqing Municipal Key Laboratory of Oral Biomedical Engineering of High Education, Chongqing, 401147, China, The Base of “111 Project” for Biomechanics and Tissue Repair Engineering, Key Laboratory of Biorheological Science and Technology, Ministry of Education, Bioengineering college, Life Science College, Chongqing University, Chongqing 400044, China – sequence: 3 givenname: Chunlin surname: Zhen fullname: Zhen, Chunlin organization: Stomatological Hospital of Chongqing Medical University, Chongqing Key Laboratory of Oral Diseases and Biomedical Sciences, Chongqing Municipal Key Laboratory of Oral Biomedical Engineering of High Education, Chongqing, 401147, China, The Base of “111 Project” for Biomechanics and Tissue Repair Engineering, Key Laboratory of Biorheological Science and Technology, Ministry of Education, Bioengineering college, Life Science College, Chongqing University, Chongqing 400044, China – sequence: 4 givenname: Liu surname: Liu fullname: Liu, Liu organization: The Base of “111 Project” for Biomechanics and Tissue Repair Engineering, Key Laboratory of Biorheological Science and Technology, Ministry of Education, Bioengineering college, Life Science College, Chongqing University, Chongqing 400044, China – sequence: 5 givenname: Zhenghong surname: Lin fullname: Lin, Zhenghong organization: The Base of “111 Project” for Biomechanics and Tissue Repair Engineering, Key Laboratory of Biorheological Science and Technology, Ministry of Education, Bioengineering college, Life Science College, Chongqing University, Chongqing 400044, China – sequence: 6 givenname: Muhammad Farrukh surname: Nisar fullname: Nisar, Muhammad Farrukh organization: The Base of “111 Project” for Biomechanics and Tissue Repair Engineering, Key Laboratory of Biorheological Science and Technology, Ministry of Education, Bioengineering college, Life Science College, Chongqing University, Chongqing 400044, China – sequence: 7 givenname: Mei surname: Wang fullname: Wang, Mei organization: The Base of “111 Project” for Biomechanics and Tissue Repair Engineering, Key Laboratory of Biorheological Science and Technology, Ministry of Education, Bioengineering college, Life Science College, Chongqing University, Chongqing 400044, China – sequence: 8 givenname: Jörg W. surname: Bartsch fullname: Bartsch, Jörg W. organization: Department of Neurosurgery, Phillips-University Marburg, Baldingerstr, Marburg 35033, Germany – sequence: 9 givenname: Enyi surname: Huang fullname: Huang, Enyi organization: Stomatological Hospital of Chongqing Medical University, Chongqing Key Laboratory of Oral Diseases and Biomedical Sciences, Chongqing Municipal Key Laboratory of Oral Biomedical Engineering of High Education, Chongqing, 401147, China – sequence: 10 givenname: Ping surname: Ji fullname: Ji, Ping organization: Stomatological Hospital of Chongqing Medical University, Chongqing Key Laboratory of Oral Diseases and Biomedical Sciences, Chongqing Municipal Key Laboratory of Oral Biomedical Engineering of High Education, Chongqing, 401147, China – sequence: 11 givenname: Li surname: Yang fullname: Yang, Li organization: The Base of “111 Project” for Biomechanics and Tissue Repair Engineering, Key Laboratory of Biorheological Science and Technology, Ministry of Education, Bioengineering college, Life Science College, Chongqing University, Chongqing 400044, China – sequence: 12 givenname: Yanhong surname: Yu fullname: Yu, Yanhong organization: Department of Urology, First People’s Hospital of Yunnan Province, Kunming, Yunnan, 650032, China – sequence: 13 givenname: Junfeng surname: Yang fullname: Yang, Junfeng organization: Department of Urology, First People’s Hospital of Yunnan Province, Kunming, Yunnan, 650032, China – sequence: 14 givenname: Xuemei surname: Jiang fullname: Jiang, Xuemei organization: The Base of “111 Project” for Biomechanics and Tissue Repair Engineering, Key Laboratory of Biorheological Science and Technology, Ministry of Education, Bioengineering college, Life Science College, Chongqing University, Chongqing 400044, China – sequence: 15 givenname: Julia Li surname: Zhong fullname: Zhong, Julia Li organization: The Base of “111 Project” for Biomechanics and Tissue Repair Engineering, Key Laboratory of Biorheological Science and Technology, Ministry of Education, Bioengineering college, Life Science College, Chongqing University, Chongqing 400044, China |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29156735$$D View this record in MEDLINE/PubMed |
| BookMark | eNp1UctOxCAUJUbj-wPcGJZuqoUWChsTNb4SH5txTRjmtoNpYQRq4q_5EX6TnRnfiWwugfPgcLbQqvMOENoj-SERvKBH3hmfdGggHdJcCLGCNoksZUYZK1Z_7DfQboyP-bBYWQkq19EGlYTxqmCbaDqC1ncQdAQc4BnCMFPQLppgZ2l-2sHE6gQRn9-OcJoG3zdTfHeRvb2e4mgbp1vrGmwdTt41PeD41OvO9xEbaFtsdDDW-U7voLVatxF2P-Y2erg4H51dZTf3l9dnJzeZKaRMGSOU07oQRUUrQgWtxxPNxhOZGyGkqTkFKHluJJSkNlXNxbgmEoTWpJIkn7BiGx0vdWf9eHi6ATfEadUs2E6HF-W1Vb9vnJ2qxj8rxoXkdC5w8CEQ_FMPManOxnkW7WCIpYjkXAomaDlA9396fZl8fu8AqJYAE3yMAWplbNLJ-rm1bRXJ1aJL9d2lWnQ5MMkf5qf4_5x31bapCA |
| CitedBy_id | crossref_primary_10_1002_mc_23035 crossref_primary_10_1016_j_bbrc_2018_04_096 crossref_primary_10_1042_BSR20191202 crossref_primary_10_1186_s13567_021_00979_x crossref_primary_10_1016_j_psj_2022_101826 crossref_primary_10_1038_s41598_019_54028_x crossref_primary_10_1016_j_drudis_2019_05_015 crossref_primary_10_1186_s12964_018_0313_3 crossref_primary_10_1007_s12032_023_02259_4 crossref_primary_10_1038_s41368_022_00161_9 crossref_primary_10_1126_science_abi8175 crossref_primary_10_1038_s41598_022_07691_6 crossref_primary_10_1002_1873_3468_13084 crossref_primary_10_3390_cancers15102673 crossref_primary_10_1111_cge_13589 crossref_primary_10_1016_j_gene_2020_145001 crossref_primary_10_1515_biol_2022_0469 crossref_primary_10_1007_s13402_024_00986_y |
| Cites_doi | 10.18632/oncotarget.6575 10.1126/science.aab4070 10.3892/ol.2015.2926 10.1111/exd.13164 10.1186/1756-9966-32-62 10.3332/ecancer.2017.721 10.3892/or.2012.2036 10.18632/oncotarget.7745 10.1007/s10585-007-9134-2 10.1158/0008-5472.CAN-16-1322 10.1016/j.oraloncology.2008.06.002 10.1038/ncb2621 10.1016/j.oraloncology.2010.06.006 10.1101/gad.13.18.2388 10.1073/pnas.96.25.14276 10.1134/S0006297910130055 10.1097/PAI.0000000000000184 10.1016/j.mce.2017.03.007 10.18632/oncotarget.9141 10.1016/j.oraloncology.2010.06.008 10.1007/s11523-015-0364-y 10.7150/jca.13054 10.1023/A:1021849217054 10.1159/000343796 10.1007/s00428-005-1264-9 10.1080/15384047.2015.1028702 10.1002/mc.22300 10.3748/wjg.v21.i31.9328 10.1016/j.ctrv.2012.06.007 10.1016/j.urolonc.2017.01.019 |
| ContentType | Journal Article |
| Copyright | Copyright: © 2017 Wu et al. 2017 |
| Copyright_xml | – notice: Copyright: © 2017 Wu et al. 2017 |
| DBID | AAYXX CITATION NPM 7X8 5PM |
| DOI | 10.18632/oncotarget.20888 |
| DatabaseName | CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
| DatabaseTitleList | PubMed MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| EISSN | 1949-2553 |
| EndPage | 85503 |
| ExternalDocumentID | PMC5689625 29156735 10_18632_oncotarget_20888 |
| Genre | Journal Article |
| GroupedDBID | --- 53G AAYXX ADBBV ADRAZ AENEX ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL CITATION DIK FRJ GX1 HYE KQ8 M48 OK1 PGMZT RPM M~E NPM 7X8 5PM |
| ID | FETCH-LOGICAL-c399t-51262f3837271282fbda5bd90c889cf62ee460c9e41fc7f68bf19e8aa17910d53 |
| IEDL.DBID | M48 |
| ISSN | 1949-2553 |
| IngestDate | Thu Aug 21 18:31:06 EDT 2025 Fri Jul 11 10:45:02 EDT 2025 Wed Feb 19 02:42:59 EST 2025 Tue Jul 01 03:28:22 EDT 2025 Thu Apr 24 23:05:59 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | true |
| Issue | 49 |
| Keywords | NF-κB hTERT CRISPR/Cas9 EMT OTSCC |
| Language | English |
| License | This is an open-access article distributed under the terms of the Creative Commons Attribution License 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c399t-51262f3837271282fbda5bd90c889cf62ee460c9e41fc7f68bf19e8aa17910d53 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 These authors contributed equally to this work and should both be considered as first authors |
| OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.18632/oncotarget.20888 |
| PMID | 29156735 |
| PQID | 1966985824 |
| PQPubID | 23479 |
| PageCount | 12 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_5689625 proquest_miscellaneous_1966985824 pubmed_primary_29156735 crossref_citationtrail_10_18632_oncotarget_20888 crossref_primary_10_18632_oncotarget_20888 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2017-10-17 |
| PublicationDateYYYYMMDD | 2017-10-17 |
| PublicationDate_xml | – month: 10 year: 2017 text: 2017-10-17 day: 17 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Oncotarget |
| PublicationTitleAlternate | Oncotarget |
| PublicationYear | 2017 |
| Publisher | Impact Journals LLC |
| Publisher_xml | – name: Impact Journals LLC |
| References | Martin (10) 2017 Zhou (27) 2015; 6 Mokbel (18) 2003; 77 Huang (22) 2016; 7 Zhou (15) 2015; 9 Prasad (17) 2017; 35 Robinson (21) 1999; 13 Salo (3) 2010; 46 Farhat (11) 2016; 55 Iyer (2) 2012; 74 Matias-Guiu (33) 2005; 446 Puri (5) 2013; 39 Chen (20) 2017; 77 Bulotta (28) 2017; 448 Li (13) 2012; 14 Yang (25) 2012; 28 Chen (9) 2017; 01 Park (16) 2015; 21 Yang (23) 2016; 7 Wang (34) 2015; 16 Wei (26) 2015; 10 Salo (4) 2010; 46 Fujimoto (19) 2013; 32 Corey (24) 1999; 96 Myerscough (8) 2008; 25 Wu (31) 2015; 30 Feigon (6) 2015; 350 Warnakulasuriya (1) 2009; 45 Yang (14) 2017; 26 Cotte (32) 2016; 10 Alaeddini (29) 2015; 23 Shrihari (12) 2017; 11 Chou (30) 2016; 7 Dontsova (7) 2010; 75 25728352 - Mol Carcinog. 2016 May;55(5):537-51 26472759 - Science. 2015 Oct 30;350(6260):aab4070 26913068 - Ecancermedicalscience. 2016 Jan 29;10:617 15856292 - Virchows Arch. 2005 May;446(5):475-82 10500096 - Genes Dev. 1999 Sep 15;13(18):2388-99 22992764 - Oncol Rep. 2012 Dec;28(6):1945-52 18071912 - Clin Exp Metastasis. 2008;25(6):665-77 26309358 - World J Gastroenterol. 2015 Aug 21;21(31):9328-36 28288903 - Mol Cell Endocrinol. 2017 Jun 15;448:34-40 20637679 - Oral Oncol. 2010 Sep;46(9):636-43 21417995 - Biochemistry (Mosc). 2010 Dec;75(13):1563-83 25916999 - Target Oncol. 2015 Dec;10 (4):565-73 26200841 - Appl Immunohistochem Mol Morphol. 2015 Sep;23(8):e12-6 23128365 - ORL J Otorhinolaryngol Relat Spec. 2012;74(5):264-70 20637681 - Oral Oncol. 2010 Sep;46(9):630-5 26689987 - Oncotarget. 2016 Mar 8;7(10 ):11364-79 12602927 - Breast Cancer Res Treat. 2003 Feb;77(3):277-84 25789002 - Oncol Lett. 2015 Apr;9(4):1567-1574 23159929 - Nat Cell Biol. 2012 Dec;14(12):1270-81 26933999 - Oncotarget. 2016 Apr 12;7(15):20180-92 22841437 - Cancer Treat Rev. 2013 Aug;39(5):444-56 27153563 - Oncotarget. 2016 Aug 16;7(33):52870-52887 28215740 - Urol Oncol. 2017 Jun;35(6):401-408 18804401 - Oral Oncol. 2009 Apr-May;45(4-5):309-16 28275390 - Ecancermedicalscience. 2017 Feb 23;11:721 28146373 - Cell Adh Migr. 2017 Sep 3;11(5-6):464-475 27513293 - Exp Dermatol. 2017 Feb;26(2):116-123 25870011 - Cancer Biol Ther. 2015 ;16(6):898-911 26640594 - J Cancer. 2015 Nov 01;6(12):1337-45 10588696 - Proc Natl Acad Sci U S A. 1999 Dec 7;96(25):14276-81 26084282 - Histol Histopathol. 2015 Nov;30(11):1283-94 27821487 - Cancer Res. 2017 Jan 15;77(2):532-544 28242612 - Development. 2017 Apr 15;144(8):1412-1424 24011086 - J Exp Clin Cancer Res. 2013 Sep 05;32:62 |
| References_xml | – volume: 7 start-page: 11364 year: 2016 ident: 23 article-title: Human telomerase reverse transcriptase (hTERT) promotes gastric cancer invasion through cooperating with c-Myc to upregulate heparanase expression publication-title: Oncotarget doi: 10.18632/oncotarget.6575 – volume: 350 start-page: aab4070 year: 2015 ident: 6 article-title: Structure of Tetrahymena telomerase reveals previously unknown subunits, functions, and interactions publication-title: Science doi: 10.1126/science.aab4070 – volume: 9 start-page: 1567 year: 2015 ident: 15 article-title: UBE2D3 is a positive prognostic factor and is negatively correlated with hTERT expression in esophageal cancer publication-title: Oncol Lett doi: 10.3892/ol.2015.2926 – volume: 26 start-page: 116 year: 2017 ident: 14 article-title: MicroRNA Let-7b inhibits keratinocyte migration in cutaneous wound healing by targeting IGF2BP2 publication-title: Exp Dermatol doi: 10.1111/exd.13164 – volume: 30 start-page: 1283 year: 2015 ident: 31 article-title: A twist tale of cancer metastasis and tumor angiogenesis publication-title: Histol Histopathol – volume: 32 start-page: 62 year: 2013 ident: 19 article-title: Activation of NF-kappaB by the RANKL/RANK system up-regulates snail and twist expressions and induces epithelial-to-mesenchymal transition in mammary tumor cell lines publication-title: Journal of Experimental & Clinical Cancer Research doi: 10.1186/1756-9966-32-62 – volume: 11 start-page: 721 year: 2017 ident: 12 article-title: Dual role of inflammatory mediators in cancer publication-title: Ecancermedicalscience doi: 10.3332/ecancer.2017.721 – volume: 28 start-page: 1945 year: 2012 ident: 25 article-title: hTERT-based therapy: a universal anticancer approach (Review) publication-title: Oncol Rep doi: 10.3892/or.2012.2036 – volume: 7 start-page: 20180 year: 2016 ident: 30 article-title: Suppression of miR-204 enables oral squamous cell carcinomas to promote cancer stemness, EMT traits, and lymph node metastasis publication-title: Oncotarget doi: 10.18632/oncotarget.7745 – volume: 01 start-page: 1 year: 2017 ident: 9 article-title: Osthole inhibited TGF β-induced epithelial-mesenchymal transition (EMT) by suppressing NF-κB mediated Snail activation in lung cancer A549 cells publication-title: Cell Adhes Migr – volume: 10 start-page: 617 year: 2016 ident: 32 article-title: Tumour progression and metastasis publication-title: Ecancermedicalscience – volume: 25 start-page: 665 year: 2008 ident: 8 article-title: Clonal diversity in carcinomas: its implications for tumour progression and the contribution made to it by epithelial-mesenchymal transitions publication-title: Clin Exp Metastasis doi: 10.1007/s10585-007-9134-2 – volume: 77 start-page: 532 year: 2017 ident: 20 article-title: Circadian Clock Gene Bmal1 Inhibits Tumorigenesis and Increases Paclitaxel Sensitivity in Tongue Squamous Cell Carcinoma publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-16-1322 – volume: 45 start-page: 309 year: 2009 ident: 1 article-title: Global epidemiology of oral and oropharyngeal cancer publication-title: Oral Oncol doi: 10.1016/j.oraloncology.2008.06.002 – volume: 14 start-page: 1270 year: 2012 ident: 13 article-title: Telomerase directly regulates NF-κB-dependent transcription publication-title: Nat Cell Biol doi: 10.1038/ncb2621 – volume: 46 start-page: 630 year: 2010 ident: 3 article-title: Prognostic evaluation of oral tongue cancer: means, markers and perspectives (I) publication-title: Oral Oncol doi: 10.1016/j.oraloncology.2010.06.006 – volume: 13 start-page: 2388 year: 1999 ident: 21 article-title: Telomere shortening and apoptosis in telomerase-inhibited human tumor cells publication-title: Genes Dev doi: 10.1101/gad.13.18.2388 – volume: 96 start-page: 14276 year: 1999 ident: 24 article-title: Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.96.25.14276 – volume: 75 start-page: 1563 year: 2010 ident: 7 article-title: Telomerase: structure, functions, and activity regulation publication-title: Biochemistry (Mosc) doi: 10.1134/S0006297910130055 – volume: 23 start-page: e12 year: 2015 ident: 29 article-title: Invasion phenotypes of oral squamous cell carcinoma publication-title: Appl Immunohistochem Mol Morphol doi: 10.1097/PAI.0000000000000184 – volume: 448 start-page: 34 year: 2017 ident: 28 article-title: Silencing of hTERT blocks growth and migration of anaplastic thyroid cancer cells publication-title: Mol Cell Endocrinol doi: 10.1016/j.mce.2017.03.007 – volume: 7 start-page: 52870 year: 2016 ident: 22 article-title: KLF4 downregulates hTERT expression and telomerase activity to inhibit lung carcinoma growth publication-title: Oncotarget doi: 10.18632/oncotarget.9141 – volume: 46 start-page: 636 year: 2010 ident: 4 article-title: Prognostic evaluation of oral tongue cancer: means, markers and perspectives (II) publication-title: Oral Oncol doi: 10.1016/j.oraloncology.2010.06.008 – volume: 10 start-page: 565 year: 2015 ident: 26 article-title: A combination of the telomerase inhibitor, BIBR1532, and paclitaxel synergistically inhibit cell proliferation in breast cancer cell lines publication-title: Target Oncol doi: 10.1007/s11523-015-0364-y – volume: 6 start-page: 1337 year: 2015 ident: 27 article-title: Knockdown of hTERT and Treatment with BIBR1532 Inhibit Cell Proliferation and Invasion in Endometrial Cancer Cells publication-title: J Cancer doi: 10.7150/jca.13054 – year: 2017 ident: 10 article-title: FGF and canonical Wnt signaling cooperate to induce paraxial mesoderm from tailbud neuromesodermal progenitors through regulation of a two-step EMT publication-title: Development – volume: 77 start-page: 277 year: 2003 ident: 18 article-title: hTERT expression in human breast cancer and non-cancerous breast tissue: correlation with tumour stage and c-Myc expression publication-title: Breast Cancer Res Treat doi: 10.1023/A:1021849217054 – volume: 74 start-page: 264 year: 2012 ident: 2 article-title: Prognostic significance of invasion depth in oral tongue squamous cell carcinoma publication-title: ORL J Otorhinolaryngol Relat Spec doi: 10.1159/000343796 – volume: 446 start-page: 475 year: 2005 ident: 33 article-title: NF-kB in development and progression of human cancer publication-title: Virchows Archiv doi: 10.1007/s00428-005-1264-9 – volume: 16 start-page: 898 year: 2015 ident: 34 article-title: Autocrine IL-8 promotes F-actin polymerization and mediate mesenchymal transition via ELMO1-NF-κB-Snail signaling in glioma publication-title: Cancer Biol Ther doi: 10.1080/15384047.2015.1028702 – volume: 55 start-page: 537 year: 2016 ident: 11 article-title: Sonic hedgehog (Shh) signaling promotes tumorigenicity and stemness via activation of epithelial-to-mesenchymal transition (EMT) in bladder cancer publication-title: Mol Carcinog doi: 10.1002/mc.22300 – volume: 21 start-page: 9328 year: 2015 ident: 16 article-title: Influence of the hTERT rs2736100 polymorphism on telomere length in gastric cancer publication-title: World J Gastroenterol doi: 10.3748/wjg.v21.i31.9328 – volume: 39 start-page: 444 year: 2013 ident: 5 article-title: Novel anticancer therapeutics targeting telomerase publication-title: Cancer Treat Rev doi: 10.1016/j.ctrv.2012.06.007 – volume: 35 start-page: 401 year: 2017 ident: 17 article-title: Inhibition of hTERT expression by MAP kinase inhibitor induces cell death in renal cell carcinoma publication-title: Urol Oncol doi: 10.1016/j.urolonc.2017.01.019 – reference: 28215740 - Urol Oncol. 2017 Jun;35(6):401-408 – reference: 28242612 - Development. 2017 Apr 15;144(8):1412-1424 – reference: 15856292 - Virchows Arch. 2005 May;446(5):475-82 – reference: 26640594 - J Cancer. 2015 Nov 01;6(12):1337-45 – reference: 20637679 - Oral Oncol. 2010 Sep;46(9):636-43 – reference: 22992764 - Oncol Rep. 2012 Dec;28(6):1945-52 – reference: 26913068 - Ecancermedicalscience. 2016 Jan 29;10:617 – reference: 23159929 - Nat Cell Biol. 2012 Dec;14(12):1270-81 – reference: 20637681 - Oral Oncol. 2010 Sep;46(9):630-5 – reference: 22841437 - Cancer Treat Rev. 2013 Aug;39(5):444-56 – reference: 26200841 - Appl Immunohistochem Mol Morphol. 2015 Sep;23(8):e12-6 – reference: 26084282 - Histol Histopathol. 2015 Nov;30(11):1283-94 – reference: 21417995 - Biochemistry (Mosc). 2010 Dec;75(13):1563-83 – reference: 27153563 - Oncotarget. 2016 Aug 16;7(33):52870-52887 – reference: 25916999 - Target Oncol. 2015 Dec;10 (4):565-73 – reference: 25789002 - Oncol Lett. 2015 Apr;9(4):1567-1574 – reference: 27513293 - Exp Dermatol. 2017 Feb;26(2):116-123 – reference: 28275390 - Ecancermedicalscience. 2017 Feb 23;11:721 – reference: 12602927 - Breast Cancer Res Treat. 2003 Feb;77(3):277-84 – reference: 25870011 - Cancer Biol Ther. 2015 ;16(6):898-911 – reference: 10500096 - Genes Dev. 1999 Sep 15;13(18):2388-99 – reference: 18804401 - Oral Oncol. 2009 Apr-May;45(4-5):309-16 – reference: 26689987 - Oncotarget. 2016 Mar 8;7(10 ):11364-79 – reference: 26933999 - Oncotarget. 2016 Apr 12;7(15):20180-92 – reference: 26472759 - Science. 2015 Oct 30;350(6260):aab4070 – reference: 24011086 - J Exp Clin Cancer Res. 2013 Sep 05;32:62 – reference: 26309358 - World J Gastroenterol. 2015 Aug 21;21(31):9328-36 – reference: 10588696 - Proc Natl Acad Sci U S A. 1999 Dec 7;96(25):14276-81 – reference: 18071912 - Clin Exp Metastasis. 2008;25(6):665-77 – reference: 27821487 - Cancer Res. 2017 Jan 15;77(2):532-544 – reference: 28146373 - Cell Adh Migr. 2017 Sep 3;11(5-6):464-475 – reference: 23128365 - ORL J Otorhinolaryngol Relat Spec. 2012;74(5):264-70 – reference: 25728352 - Mol Carcinog. 2016 May;55(5):537-51 – reference: 28288903 - Mol Cell Endocrinol. 2017 Jun 15;448:34-40 |
| SSID | ssj0000547829 |
| Score | 2.2784474 |
| Snippet | Locoregional lymph nodes metastasis in oral tongue squamous cell carcinoma represents one of important and common prognostic factors for poor clinical outcome.... |
| SourceID | pubmedcentral proquest pubmed crossref |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | 85492 |
| SubjectTerms | Research Paper |
| Title | Telomerase reverse transcriptase mediates EMT through NF-κB signaling in tongue squamous cell carcinoma |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/29156735 https://www.proquest.com/docview/1966985824 https://pubmed.ncbi.nlm.nih.gov/PMC5689625 |
| Volume | 8 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT-MwEB7xuHBZgWDZ8pKROCFlt3Ecxz4gBIiCkMqplXqLHD8WpJJCHxL8NX4Ev4mZNC2wsJwiJbalzMSeb5zx9wEcZEoULi3QA0rKSMTWRJoXJnIIDURifZw4Ou_cvpaXXXHVS3sLMJO3qg04-jK1Iz2p7rD_-_Hh6Rgn_BFNeCUT_mdAPAZV4TQmfJjSLcIyBqaMlBzaNdqfUn0LjIe6_rf5ZU_iBtaY0mSV_Nu7QPUJff5bRPkuKrVW4UcNJ9nJ1P9rsODLdbjp-P6ANptGnhFD0xCvY4pJ1QpBd6vzIggy2Xm7w2qpHnbdil6eTxlVdBg6pM5uS4bI8O_Es9HDxNAeAaN9fmZJf6gc3JkN6LbOO2eXUa2oEFkEIuMIo7vkgZJSnmFg4qFwJi2cblqltA2Sey9k02ov4mCzIFURYu2VMURi2nRp8hOWykHpfwELwSbCWCLwQ7N6Z3jqEhuMM9akocga0JyZL7c13TipXvRzSjvI-Pmb8fPK-A04nHe5n3JtfNd4f-aTHGcEvb4pPVoixzVFapUqLhqwOfXRfLiZcxuQffDevAGxbX98Ut7eVKzbqVQak8Wt_465DSucYj6Vu2Q7sDQeTvwuIpZxsQeLF714r_oaXwEt6vJF |
| linkProvider | Scholars Portal |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Telomerase+reverse+transcriptase+mediates+EMT+through+NF-%CE%BAB+signaling+in+tongue+squamous+cell+carcinoma&rft.jtitle=Oncotarget&rft.au=Wu%2C+Yan&rft.au=Bian%2C+Chunxiang&rft.au=Zhen%2C+Chunlin&rft.au=Liu%2C+Liu&rft.date=2017-10-17&rft.eissn=1949-2553&rft.volume=8&rft.issue=49&rft.spage=85492&rft_id=info:doi/10.18632%2Foncotarget.20888&rft_id=info%3Apmid%2F29156735&rft.externalDocID=29156735 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1949-2553&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1949-2553&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1949-2553&client=summon |